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Abstract We have observed that the extracellular domain of
TPRI  and protectin (CD59), an inhibitor of the membrane attack
complex of complement, share structural features, a distinct spac-
ing of ten cysteines and a C-terminal ‘Cys-box’. Based on these
common features and the recently determined NMR-structure of
protectin, a three-dimensional model for the extracellular domain
of TPRI  was constructed. After energy minimization and molec-
ular dynamics simulation, a structure with four extending fingers
(pes quattvordigitorum) and two clusters of charged residues was
obtained. This model provides a view to the understanding of
interactions between TPRI,  TPRII  and TGF/3 during ligand rec-
ognition and signal transduction.
Key woru!!: Receptor; Transforming growth factor-,&
Protein-serinelthreonine kinase; Protein structure, tertiary;
Complement
1. Introduction
Transforming growth factors-/?-B3 (TGFB) are a group of
cytokines, which appear usually as homodimers with an M, of
about 2.5 kDa. TGFps participate in several different local or
systemic biological responses, e.g. inflammation, host defence,
growth regulation, cellular differentation, development and tis-
sue repair [ 11. The TGFB group of cytokines belongs to a larger
family of structurally related proteins that include activins,
inhibins, Miillerian inhibiting substance (MIS). bone morpho-
genetic proteins (BMPs) and osteogenic proteins (OPs) [l].
Many of these cytokines bind to cell membrane receptors that
have intracellular serinelthreonine kinase domains (activin re-
ceptor-like kinases; ALKs) [2-61.
The effects of TGF,& are currently known to be mediated by
a series of molecular interactions. First, TpRIl binds TGFB.
which is free in the fluid-phase or presented by TPRIIIlendoglin
[7]. Thereafter the TPRII-TGFP complex interacts with TBRI.
TPRII  is a constitutively active protein kinase, but a stable
complex with both TGFB and TBRI is needed for signal prop-
agation through phosphorylation of T/?RI by T/?RII in a heter-
odimeric or -tetrameric complex [ 1,5-91.
TBRI and activ-in receptor type IB (ActR-IB, ALK4) have
nearly identical intracellular kinase domains and mediate simi-
lar responses although they interact with different type II recep-
tors and ligands. Thus, it is likely that type I receptors deter-
mine the specificity of responses to various type II-ligand-type
I complexes [7.10]. It is probable that mainly the extracellular
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part of T/3Rl is needed for the specific recognition of the
T~Rll~TGF~ complex [l,ll].
The extracellular parts of T/?RI and ALKI-4-6 contain each
of about 100 amino acids including 10 cysteines [2,3,5.6]. Their
sequence homology with each other suggests a common do-
main structure within this family. At present no information is
available about the tertiary structure of these domains, mainly
because of difficulties in obtaining enough protein for NMR
spectroscopy or X-ray crystallography.
We have observed that the extracellular domains of T/?RI
and ALKl-4.6 share structural features with another family of
membrane proteins that include protectin (CD59), three do-
mains of the receptor for urokinase-type plasminogen activator
(uPAR), mouse lymphocyte protein Ly-6 and a viral membrane
protein of Herpes saimiri (HVS-15) [12]. In addition, there is
similarity to several snake venom neurotoxins [13] and a re-
cently described human antigen E48 [ 141. The basic domain in
this putative superfamily (‘protectin-superfamily’) is character-
ized by the conserved distribution of 10 cysteine residues within
a domain of 65-85 amino acids and a highly conserved C-
terminal sequence CCXXXXCN (‘cysteine box’). The index
molecule protectin (CD59) is a glycosylphosphatidylinositol
(GPI)-anchored membrane protein containing 77 amino acids.
The tertiary structure of CD59 has been determined by two-
dimensional NMR spectroscopy [ 15,161. All the cysteine pair-
ing patterns of the various family members resolved so far have
been found to be analogous, although some domains lack one
disulphide bridge. Thus it seems that the internal cysteine skel-
eton serves as a preferred and compact frame for these proteins
of different function. It is likely that also the rest of the family
shares the same cysteine pairing pattern. Therefore, it is possi-
ble to construct tertiary structure models for the extracellular
domains of the ALK-type protein kinases by using protectin as
a template in computer-aided homology modelling. In this
study, we have modelled the structure of the extracellular do-
main of T/?RI which is an important and functionally best
characterized representative of the receptor-type serinelthreon-
ine protein kinases.
2. Materials and methods
Co puter-aided molecular modelling was performed with the In-
sight11 program package (version 2.2.1, Biosym Technologies Inc., San
Diego, CA) using a Silicon Graphics Iris Indigo XZ 4000 work-station
(Silicon Graphics Inc., Mountain View, CA). The Biopolymer and
Homology modules of Insight11 were used to build a preliminary model
of the extracellular domain of TPRI. Protectin (CD59) was found to
be the optimal template for Tj?RI after screening of all protein struc-
tures available in the Brookhaven Protein Databank (PDB; release #68,
April 1994; Brookhaven National Laboratory. Upton, NY, USA) [17].
The 10 conserved cysteines of protectin were used as a basis for homol-
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Fig. I Alignmsnt of cqstcinc rcsiduch in pi-otectin (CD5Y) and similar domains m other human membrane proteins. (a) Ahgnment of protectm and
tort-esponding parts of extracellular domains of the type I TC;Fp rcccplor family (ALKI-5). three domains of the receptor for urokinase-type
plasminogen activator (uPARI-3) and human antigen E48. The box s indicate the alignment ofcysteine residues and the C-terminal ‘Cys-box’. No
attempt to align other residue5 \+a> made. (b) Alignment of protectin and the extracellular domain of T/?RI (ALK-5). The internal ‘core’ residues
i l-4. I5 20. 39. 52 54. 66 74) of the extracellular domain of T/?RI are underlined. The sites of extending loops are numbered as I-IV. The residues
of TPRI are numbered according to the frame of protectin.
ogy alignment. The most N-terminal par{ of TDRI ua4 not modcllcd.
because the sequence of the template molecule reached only tv,o amin
acids N-terminal from the tirsl cysteine. The amino acida of the c~-
tracellular domain of TDRI were numbered by beginning from residue
Leu-IO (as counted from the end of the putative hydrophobic leadel
sequence).
The CD50 template btructurc M;I~ kindly pro\ ided bq M. Fletcher
and D. Neuhaus (Laboratory for Molecular Biology. MRC‘. Cam-
bridge) (PDB accession code Ic q. structure #I ). It represents the one
of the 50 structures calculated from NMR-data that has the low at
distance constraint violation energy [I 51. Four loops (I ~IV) wcrc needed
to complete the preliminary model structure (Fig. I ). The best arailablc
loop structures were searched fi-om all protein structureb deposited m
PDB using anchors of3 5 residues. In choosing the loop structures the
following criteria were used: amino acid sequence, distance between the
first C,-atoms of the anchors, rms-deviation. secondary structure (r-
helix./&heet) prediction based on the sequence ofTPR1 and estimation
of suitability to the overall tcrtiar! htructurc. Model loops I (residues
5 I4 of TBRI) and II (residues II  18) mere obtained from the snake
venom toxin family members neurotoxin-B (PDB accession cod  lnxb)
and neurotoxin-II ( nor). respectivclq. Loops III (residues 40-51) and
IV (residues 55~ 65) were parts of human i munoglobulin light chain\
2rhe and 2mcg. respectively.
The preliminary model rtructurc ofTpR1 wa:, soaked m a watc~-bo~
of 1392 water molecules (dimensions of the box were 44 x 52  ?I AI
to achieve about 6 A ofnater surrounding the whole protein. Using the
Discocer module (version 2.Y.5) the water molecules and the protein
were allowed to relax by diminishing. gradually the fixations of the
protein between succcssi\c energy mmlmirations. The energy minimi-
rations wcrc performed using both the steepest descents and conjugarc
gradient algorithms. Molecular dqnamlcs mlulations were performed
by gradually increasing the temperature of the system. The target \+as
simulated I .O ps at 100 K. 20.0 pb al 300 K and 196.0 ps at 600 K using
a I .O fs time step throughout. The calculations* were made under full
periodic boundary conditions u\mg a I2 I3 A cut-off distance and
CVFF as forcefield. To adjust the waterbox to an altered conformation
ofthe protein. the dimensiona of the waterbox and the amount ofwatel
molecules were changed three times (amount of HZ0 m lecules was
176X. 152 I and 1490, respectively). The average pressur in the uater-
box during the simulation at 600 K was 4800 bars.
After a total of217 ps molecular dynamics simulation. IO structure.\
\vere selected from the last IO6 p\ (at 600 K) usinp a local potentull
a,
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1,1g. 7. Rms-deviation (rmsd) and potential energy of the model of the
TPRI extracellular domam as a function of molecular dynamics simula-
tion time. (a) Rmsd of all atoms or backbone atoms (C. C,. N. 0) of
tither all residues or ‘core’ residues of the model. Rmsd values were
calculated by comparing the coordinates of the model during dynamics
snnulation to the coordinates of the preliminary model. (b) Potential
energy of the model as a function of dynamics simulation time. The ten
;trrowheads indicate time points for selecting structures at local poten-
teal energy minima These ten model structures were subjected to en-
cl-gy-minimization (structures #4 10 are shown in Fig. 3). The size ot
rhe Lvatcrbox was changed three times: at I ps, 21 ps and I I8 ph.
Fig. 3. Tertiary model structures of the extracellular domain of T/?RI. Backbone traces of seven energy-minimized model structures after sup<
pos:ition of the ‘core’ residues. Each of the seven structures were energy-minimized from a local potential energy minimum found during dyna
simlulation at 600 K. The spectrum between yellow and red indicates the order of structures as a function of simulation time in the order shov
Fig. 2b (yellow = #4. red = #IO). Disulphide bridges are shown in grey.
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Fig. 4. A comparison between the template structure protectin (right) and the extracellular domain of TBRI (left). TheT/?Rl structure is the
with the lowest potential energy of the ten energy-minimized structures (structure #lo;see Fig. 2b). Both structures are shown as top-
side-projections. Sulphur atoms of cysteines are shown in yellow
one
and
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energy minimum of the entire system (water molecules and the protein)
as a criterion. The 10 structures were energy minimized in their water-
boxes using the conjugate gradient algorithm until the maximum deriv-
ative was below 0.001 kcal. A-‘. Coordinates of one of the ten struc-
tures (#lo) have been deposited in the Brookhaven Protein Databank
(accession code ITBI).
3. Results
3. I. Sequence similarity between TaRI  and protectin
Sequence homology between protectin and T/?RIIALK14 is
limited to the 10 cysteines, amino acids surrounding them and
to the CCXXXXCN ‘Cys-box’ (Fig. la). As seen in Fig. lb the
number of amino acids between the neighbouring cysteines is
different in T/?RI and protectin. Thus a total of four loops were
constructed to the model from coordinates in the Brookhaven
PDB to generate a preliminary model structure.
3.2. Course of the modelling
The preliminary model structure of the extracellular domain
of T/?RI was soaked in a w terbox and subjected to energy
minimization and molecular dynamics simulation. The course
of molecular dynamics simulation was analyzed by calculating
root mean square deviations (rmsd) of individual structures at
various time points compared to the preliminary tertiary struc-
ture (Fig. 2a). Rmsd was calculated for four different sets of
atoms: (1) all atoms in all residues; (2) backbone atoms (C,, C,
0, N) in all residues; (3) all atoms in ‘core’ residues, corre-
sponding to internal residues adopted from protectin coordi-
nates: 14, 15-20, 39, 52-54, 66-74; and (4) backbone atoms in
‘core’ residues.
The preliminary model structure underwent a series of con-
formational changes during the energy minimization proce-
dure, as the rmsd for all residues after the minimization was
somewhat high (3.30 A for all atoms, 2.77 A for backbone
atoms). During dynamics simulation the rmsd of all residues
(all or backbone atoms) increased in a fairly linear fashion to
reach a plateau after an about 130 ps simulation (Fig. 2a). The
rmsd-plateau level was about 7 A for all atoms of the molecule
and 6 A for all backbone atoms.
During minimization the rms of the ‘core’ residues changed
I .96 A for all atoms and 1.38 A for the backbone. These
changes constitute about 50% of total rmsd after a 217 ps
dynamics simulation (1.96 vs. 3.85 for all ‘core’ atoms and 1.38
vs. 3.0 for backbone atoms of the ‘core’). As seen in Fig. 2a,
the rmsd of ‘core’ residues varied within a relatively small range
during the 196 ps simulation at 600 K (34 A for all atoms and
2-3 A for the backbone). Potential energy of the model struc-
ture varied only a little during dynamics simulation except
during changes in temperature or in the size of the waterbox
(see section 2). No radical global potential energy minimum
was reached during the simulation procedure (Fig. 2b).
3.3. Analysis of the model
Ten structures each representing a local potential energy
minimum of the waterbox-system were subjected to energy-
minimization. After minimization the potential energies of the
ten model structures were 750-1150 kcal/mol while potential
energy of the similarly energy minimized template structure was
665 kcal/mol. The rmsd values against the preliminary model
before any minimization or dynamics simulation were 4.8-7.5
A for all atoms of the molecule (data not shown).
Seve  of the ten energy-minimized structures are shown in
Fig. 3. These structures cover the last 90 ps of the dynamics
simulation, when the rmsd of the whole molecule had reached
the plateau described above. After superimposing the ‘core’
residues of these structures it can be seen that the core appears
relatively stable whereas the loops, especially their distal parts,
shift somewhat out of the average plane of the corresponding
loops. This is also observed numerically as the rmsd between
the core residues of each possible pair of the seven energy-
minimized structures was below 2.5 A for all core atoms and
below 1.8 A for backbone of the core.
As compared with the NMR structure of the template mole-
cul  protectin, the overall model structure of the extracellular
domain of T/3RI was quite similar (Fig. 4). The folding pattern
in th  model of the extracellular domain of TBRI appears like
a pes quattvordigitorum with three fingers pointing forward
and one backwards. As indicated by visual and Ramachandran
plot analysis (data not shown) the model structure of the ex-
tracellular domain of T/JR1 contains 1.5 turns of a-helix (resi-
dues 4349). Both the template molecule protectin and the
model structure contain five long B-sheet structures. In addi-
tion, the model has short stretches of B-sheet.
3.4. Properties of the model structure
As charged amino acids and surface hydrophobic patches are
often involved in intermolecular protein-protein interactions,
we analyzed their distribution in the 3D-model of TDRI. The
ha ged amino acids seem to be located in two clusters on the
surface of the extracellular domain of TaRI (Fig. 5). One clus-
ter is located distally between the first and second loops and
contains eight charged residues: three lysines (10, 3 1, 75) three
aspartic (11, 30, 71) and two glutamic acids (27, 77). In the
middle of this cluster there are also three histidines (6, 34, 72).
The other cluster is on the ‘back-finger’, loop III. It contains
x charged residues: two arginines (47,49), three aspartic acids
(18,43,48) and one glutamic acid (41). The uncertainty regard-
ing local conformation in loop III does not affect the existence
of this cluster, since the obtained alternative conformations all
preserve the cluster. Outside these two clusters there is only one
charged residue in the modelled structure (Lys-58). On the
surface of the model there is one major hydrophobic cluster
(residues 22, 39, 42, 44, 45, 51) located within and near the
second charge cluster.
4. Discussion
Modelling of the structure of the extracellular domain of
TBRI was based on the NMR-structure of protectin (CD59)
[l&16]. Protectin has ten cysteine residues, three of which are
located in a C-terminal cysteine box. This cysteine pattern is
conserved in the extracellular domain of T/?RI as well as in the
other members of the TBRIIALK-family and uPAR (with the
exception of uPAR domain #I with eight cysteine residues)
(Fig. 1). The pairing of the cysteines also appears to be con-
served as all structures of the superfamily members determined
so far have shown an analogous pairing pattern (protectin,
uPAR domain #l and twelve snake venom neurotoxins)
[ 12,181. On this basis we made the fundamental assumption that
th  cysteine pairs are formed similarly in the extracellular do-
main of T/IRI. Although it is likely that TBRI has this cysteine
pairing pattern it remains to be experimentally verified. In the
TS. Jokiranra et ul. I FEBS Letters 376 (1995) 31-36
Fig. 5. Distribution of charged residues in the model of the extracellular domain of TBRI. Side chains of charged residues as seen fromaboveand
.ered intwo boxes. Side chains of histidines are shown in vellow. Side chains of the positively and negatively charged amino acidsare shown
in blue and red, respectively.
less likely case that the cysteine pairing is significantly different
in TBRI and the ‘protectin superfamily’ the model is not valid.
As seen in Fig. 2a the conformation of the core structures of
the model, adopted directly from the coordinates of protectin,
changed only moderately during the modelling procedure
(rmsd for the backbone < 3 A). The conformation of the whole
model changed much more, probably because of variation in
the extending loops. However, a plateau in the rmsd for all
atoms was reached at about 130 ps. This rmsd-plateau may
reflect attainment of a compact or semi-compact model struc-
ture, as indicated by a rather small variation in the rmsd values
during this time (Fig. 2a) and small rmsd of the core of the seven
energy-minimized structures chosen from the course of the last
90 ps of dynamics simulation (rmsd for the backbone of the
core < 1.8 A). As a rather stable core structure was reached
during dynamics simulation in water at 600 K, the tertiary
structure of the modelled domain seems to be firmly stabilized
by the five disulphide bridges.
The overall rmsd level of about 7 A for all atoms of the
molecule and 6 A for the whole backbone suggests that some
parts of the preliminary model structure were quite different
from the final model conformation. This is explained mainly by
changes in the conformation of the loops. However, consider-
ing the large amount of variation in the loops, model structures
of the outer halves of loops II and IV (residues 26-33 and
57-64) must be considered undetermined. There is also some
uncertainty regarding the placement of the short a-helix in loop
III. On the other hand, the structure of loop I appears well
determined. After minimization, the potential energies of the
ten model structures were somewhat higher than that of the
template structure. The likeliest cause for this is the computa-
tional procedure, i.e. energy minimization from a conformation
taken from a high temperature simulation. The energy minimi-
zation will produce a conformation which is still closer to a high
temp rature state than to a room temperature state, and it will
therefore have a higher potential energy (compare the increase
in potential energy on raising the temperature, Fig. 2b). Ideally,
the proper way to compare the potential energies would be to
anne l the ten conformations, i.e. lower the temperature slowly
from 600 K to 300 K during simulation. This amounts to a
considerable amount of computer time and was deemed to be
outside the scope of this work.
The five cysteine pairs are probably a major factor in stabiliz-
ing the tertiary structure of the members of the protectin-super-
family. Thus it is not surprising that the model structure of
T/?RI resembles protectin in containing three ‘fingers’ protrud-
ing forward in a plane (Fig. 4). Both molecules are rich in
P-sheet structure and contain one a-helix, although the latter
is found at a different position. The two molecules show differ-
ences in the surface distribution of charged and hydrophobic
residues. These differences probably reflect different biological
properties of the molecules.
The model structure of T/?Rl may provide some insight into
the physiological activities of TDRI. It is known that the ex-
tr cellular part of TBRI is needed to specifically recognize the
TBRII-TGF/?-complex [7,10]. However, the exact nature of the
binding of the TbRIILTGF/I  complex to TPRI is not known.
Further, as the specificity of the biological response to TGFB
related cytokines (activins, inhibins, BMP  MIS and OPs) in
different cell types seems to be defined by the particular type
36
I receptors. the model could help understand the mechanism
of this specificity as well as the mechanisms behind the multi-
functional nature of these cytokines. Practically, the most im-
portant application f the current model is that it provides a
basis for site-directed mutagenesis studies of the type I family
of TGFP and activin receptors. The surface of the modelled
domain of TjIRI bears two charge clusters (residues 10, I I. 27.
30. 31. 71. 75. 77 and 18. 39-54) the latter located next to the
hydrophobic patch. The former charge cluster is located on
TBRI  analogously to a recently described functional site of
erabutoxin a [19], a snake toxin homologous to protectin and
the extracellular domain of TDRI. It is possible that the two
clusters are involved in the biological functions of TPRI and
thus provide a fascinating target for mutagenesis studies. The
present model and the current biochemical data suggest that
these clusters could constitute two distinct binding sites in the
extracellular domain of TBRI, perhaps one for TGFP and the
other for TPRII.
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